Ocuphire Pharma Probability of Future Stock Price Finishing Over 13.07

OCUPDelisted Stock  USD 1.13  0.06  5.04%   
Ocuphire Pharma's future price is the expected price of Ocuphire Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Ocuphire Pharma performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
  
Please specify Ocuphire Pharma's target price for which you would like Ocuphire Pharma odds to be computed.

Ocuphire Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ocuphire Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ocuphire Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ocuphire Pharma is now traded under the symbol IRD. Please update your portfolios or report it if you believe this is an error. Report It!
Ocuphire Pharma is not yet fully synchronised with the market data
Ocuphire Pharma generated a negative expected return over the last 90 days
Ocuphire Pharma may become a speculative penny stock
Ocuphire Pharma has high historical volatility and very poor performance
Ocuphire Pharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 19.05 M. Net Loss for the year was (9.99 M) with loss before overhead, payroll, taxes, and interest of (14.58 M).
Ocuphire Pharma currently holds about 17.15 M in cash with (1.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83.

Ocuphire Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ocuphire Stock often depends not only on the future outlook of the current and potential Ocuphire Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ocuphire Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding21.6 M
Cash And Short Term Investments50.5 M

Ocuphire Pharma Technical Analysis

Ocuphire Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Ocuphire Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ocuphire Pharma. In general, you should focus on analyzing Ocuphire Stock price patterns and their correlations with different microeconomic environments and drivers.

Ocuphire Pharma Predictive Forecast Models

Ocuphire Pharma's time-series forecasting models is one of many Ocuphire Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ocuphire Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Ocuphire Pharma

Checking the ongoing alerts about Ocuphire Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ocuphire Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ocuphire Pharma is now traded under the symbol IRD. Please update your portfolios or report it if you believe this is an error. Report It!
Ocuphire Pharma is not yet fully synchronised with the market data
Ocuphire Pharma generated a negative expected return over the last 90 days
Ocuphire Pharma may become a speculative penny stock
Ocuphire Pharma has high historical volatility and very poor performance
Ocuphire Pharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 19.05 M. Net Loss for the year was (9.99 M) with loss before overhead, payroll, taxes, and interest of (14.58 M).
Ocuphire Pharma currently holds about 17.15 M in cash with (1.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Ocuphire Stock

If you are still planning to invest in Ocuphire Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocuphire Pharma's history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stocks Directory
Find actively traded stocks across global markets